NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Expanded Access to Upadacitinib

AvailableN/A

Sponsor: AbbVie

Conditions: Crohn Disease, Ulcerative Colitis, Idiopathic Arthritis (Including sJIA, pJIA, or JPsA), Atopic Dermatitis, Rheumatoid Arthritis

Interventions: Upadacitinib

This is an expanded access program (EAP) for eligible participants. This program is designed to provide access to upadacitinib prior to approval by the local regulatory agency. Availability will depend on territory eligibility. A medical doctor must decide whether the potential benefit outweighs the risk of receiving an investigational therapy based on the individual patient's medical history and program eligibility criteria.

Eligibility overview

Sex: ALL

Healthy volunteers: No

Study type: EXPANDED_ACCESS

Eligibility criteria

Exclusion Criteria:

* There are other suitable treatment options.
* The participant qualifies for ongoing clinical trials.